Abstract:BACKGROUND With increasing significance of developmental programming effects associated with placental dysfunction, more investigations are devoted to improving the characterization and understanding of placental signatures in health and disease. The placenta is a transitory but dynamic organ adapting to the shifting demands of fetal development and available resources of the maternal supply throughout pregnancy. Trophoblasts (cytotrophoblasts, syncytiotrophoblasts, and extravillous trophoblasts) are placental-specific cell types responsible for the main placental exchanges and adaptations. Transcriptomic studies with single-cell resolution have led to advances in understanding the placenta's role in health and disease. These studies, however, often show discrepancies in characterization of the different placental cell types. OBJECTIVE AND RATIONALE We aim to review the knowledge regarding placental structure and function gained from the use of single-cell RNA sequencing (scRNAseq), followed by comparing cell-type-specific genes, highlighting their similarities and differences. Moreover, we intend to identify consensus marker genes for the various trophoblast cell types across studies. Finally, we will discuss the contributions and potential applications of scRNAseq in studying pregnancy-related diseases. SEARCH METHODS We conducted a comprehensive systematic literature review to identify different cell types and their functions at the human maternal–fetal interface, focusing on all original scRNAseq studies on placentas published before March 2023 and published reviews (total of 28 studies identified) using PubMed search. Our approach involved curating cell types and subtypes that had previously been defined using scRNAseq and comparing the genes used as markers or identified as potential new markers. Next, we reanalyzed expression matrices from the six available scRNAseq raw datasets with cell annotations (four from first trimester and two at term), using Wilcoxon rank-sum tests to compare gene expression among studies and annotate trophoblast cell markers in both first trimester and term placentas. Furthermore, we integrated scRNAseq raw data available from 18 healthy first trimester and nine term placentas, and performed clustering and differential gene expression analysis. We further compared markers obtained with the analysis of annotated and raw datasets with the literature to obtain a common signature gene list for major placental cell types. OUTCOMES Variations in the sampling site, gestational age, fetal sex, and subsequent sequencing and analysis methods were observed between the studies. Although their proportions varied, the three trophoblast types were consistently identified across all scRNAseq studies, unlike other non-trophoblast cell types. Notably, no marker genes were shared by all studies for any of the investigated cell types. Moreover, most of the newly defined markers in one study were not observed in other studies. These discrepancies were confirmed by our analysis on trophoblast cell types, where hundreds of potential marker genes were identified in each study but with little overlap across studies. From 35 461 and 23 378 cells of high quality in the first trimester and term placentas, respectively, we obtained major placental cell types, including perivascular cells that previously had not been identified in the first trimester. Importantly, our meta-analysis provides marker genes for major placental cell types based on our extensive curation. WIDER IMPLICATIONS This review and meta-analysis emphasizes the need for establishing a consensus for annotating placental cell types from scRNAseq data. The marker genes identified here can be deployed for defining human placental cell types, thereby facilitating and improving the reproducibility of trophoblast cell annotation.

Sex at the interface: the origin and impact of sex differences in the developing human placenta

High-throughput mRNA sequencing of human placenta shows sex differences across gestation

Sex differences in innate and adaptive immunity impact fetal, placental, and maternal health

Sexual dimorphism in placental development and its contribution to health and diseases

Fetal sex specific differences in human placentation: a prospective cohort study

Sexually dimorphic DNA methylation and gene expression patterns in human first trimester placenta

Single-cell transcriptional profiling reveals cellular and molecular divergence in human maternal–fetal interface

Sex-specific phenotypical, functional and metabolic profiles of human term placenta macrophages

Human Placental Adaptive Changes in Response to Maternal Obesity: Sex Specificities

RNA sequencing reveals the developmental onset of autosomal gene expression differences in male and female extravillous trophoblasts

Sex-based disparities in DNA methylation and gene expression in late-gestation mouse placentas

Placental Endocrine Activity: Adaptation and Disruption of Maternal Glucose Metabolism in Pregnancy and the Influence of Fetal Sex

Deciphering the Epigenetic Landscape: Placental Development and Its Role in Pregnancy Outcomes

Variation of microRNA expression in the human placenta driven by population identity and sex of the newborn

Genome-wide identification of transcriptional enhancers During human placental development and association with function, differentiation, and disease

Expression quantitative trait loci (eQTLs) in human placentas suggest developmental origins of complex diseases

Distinct immune responses to HIV and CMV in Hofbauer cells across gestation highlight evolving placental immune dynamics

New era of trophoblast research: integrating morphological and molecular approaches

Seasonally variant gene expression in full-term human placenta

Sexually dimorphic methylation patterns characterize the placenta and blood from extremely preterm newborns

Revealing the molecular landscape of human placenta: a systematic review and meta-analysis of single-cell RNA sequencing studies